Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Publication

Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Journal Paper/Review - Jul 1, 2022

Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas

Citation

Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.

Type

Journal Paper/Review (English)

Journal

Oncology 2022; 101

Publication Date

Jul 1, 2022

Issn Electronic

1423-0232

Pages

145-152

Brief description/objective

The evaluation of symptom burden, performance status, and neurological function is still challenging in glioblastoma (GBM) patients. Patients may suffer from a wide spectrum of neurological symptoms like cognitive deficits, aphasia, or hemiparesis, which interfere to report to comprehensive questionnaires. However, an integrated and reliable neuro-oncological assessment is the key in the clinical management and in the evaluation of treatment benefits for GBM patients.